Clofarabine, Idarubicin, and Cytarabine (CIA) as Frontline Therapy for Patients ≤60 Years with Newly Diagnosed Acute Myeloid Leukemia (AML)

類似資料

• Clofarabine plus Low-Dose Cytarabine Followed by Clofarabine plus Low-Dose Cytarabine Alternating with Decitabine in AML Frontline Therapy of Older Patients
  著者:: Faderl, Stefan, 等
  出版事項: (2012)
• Prognostic Significance of Alterations in IDH Enzyme Isoforms in Patients With AML Treated With High Dose Cytarabine and Idarubicin
  著者:: Ravandi, Farhad, 等
  出版事項: (2011)
• Clofarabine plus low-dose cytarabine is as effective as and less toxic than intensive chemotherapy in elderly AML patients
  著者:: Takahashi, Koichi, 等
  出版事項: (2015)
• Final Results of a Phase II Trial of Clofarabine and Low-Dose Cytarabine Alternating with Decitabine in Older Patients with Newly Diagnosed Acute Myeloid Leukemia
  著者:: Kadia, Tapan M., 等
  出版事項: (2015)
• A Randomized Phase 2 Study of Idarubicin and Cytarabine With Clofarabine or Fludarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia
  著者:: Jabbour, Elias, 等
  出版事項: (2017)